Meeting
2016 ASCO Annual Meeting
Effect of radiotherapy treatment modalities on survival in stage IIa prostate cancer: A National Cancer Data Base (NCDB) analysis.
Authors
Timothy Dean Malouff
Creighton University School of Medicine, Omaha, NE
Timothy Dean Malouff , Sydney Marsh , Peter T. Silberstein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 34, 2016 (suppl; abstr 5069)
DOI
10.1200/JCO.2016.34.15_suppl.5069
Abstract #
5069
Poster Bd #
326
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Sexual function after primary external beam radiation therapy (EBRT) for prostate cancer in a large cohort of men with long-term follow-up.
First Author: Domenique Escobar
Poster
2022 ASCO Genitourinary Cancers Symposium
External beam radiation therapy with or without brachytherapy boost for low PSA, high-grade prostate cancer.
First Author: Benjamin Walker Fischer-Valuck
Poster
2021 Genitourinary Cancers Symposium
Intraprostatic calcification and biochemical recurrence in men treated with Cs-131 prostate brachytherapy.
First Author: Michael D Schad
Poster
2020 Genitourinary Cancers Symposium
18-year prostate cancer-specific mortality after prostatectomy, brachytherapy, external beam radiation therapy, hormonal therapy, or monitoring for localized prostate cancer.
First Author: Annika Herlemann